Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE
NCT06892145
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus (SLE)
Refractory
Interventions
BIOLOGICAL:
MC-1-50
Sponsor
Chongqing Precision Biotech Co., Ltd
Collaborators
[object Object]